Your browser doesn't support javascript.
loading
Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer: A Retrospective Case Series.
Joris, Sofie; Fontaine, Christel; Decoster, Lore; Vanderauwera, Jacques; Thielemans, Kris; Waelput, Wim; DE-Grève, Jacques.
Afiliação
  • Joris S; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium; Sofie.Joris@uzbrussel.be Jacques.Degreve@uzbrussel.be.
  • Fontaine C; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Decoster L; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Vanderauwera J; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Thielemans K; Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium.
  • Waelput W; Department of Pathology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • DE-Grève J; Department of Genetics, Universitair Ziekenhuis Brussel, Brussels, Belgium Sofie.Joris@uzbrussel.be Jacques.Degreve@uzbrussel.be.
Anticancer Res ; 42(3): 1433-1437, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35220236
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nivolumabe / Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nivolumabe / Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article